Related Experiment Video
Updated: Dec 31, 2025

Demonstration of the Rat Ischemic Skin Wound Model
Published on: April 1, 2015
Effects of anticoagulant drugs on wound healing process in a rat model: a comparative study
Deniz Çevirme1, Ömer Faruk Savluk2, Eylül Kafalı Başaran3
1Department of Cardivascular Surgery, Kartal Koşuyolu Yüksek İhtisas Research and Education Hospital, Istanbul, Turkey.
Objective:
This study aims to compare the efficacy of enoxaparin, rivoraxaban and dabigatran on wound healing using a rat model.
Method:
Sprague-Dawley female rats (n=56), 10-12 weeks old, weight 245±30g, were used in this study. The rats were divided into four equally-sized groups. A type 1 (secondary wound healing) and type 2 (primary wound healing) wound was opened surgically on each rat in each group. Anticoagulent drugs enoxaparin, rivoraxaban and dabigatran and physiological saline solution were administered to Groups 1, 2, 3 and 4, respectively. After wound healing was scored tissue samples were taken from euthanised rats at days five and 10 and examined histologically. Since time was used as a classification (days five and 10), a time effect was included.
Results:
There was no statistically significant difference in total score distribution in rats between type 1 secondary wounds for days five and 10 (p>0.05). There was no statistically significant difference in the overall score distribution in rats between type 2 primary wounds for days five and 10 (p>0.05).
Conclusion:
In addition to the use of low molecular weight heparin with well-known anticoagulation activity, the new generation oral medications are used efficiently in thromboembolic diseases. However, there was no evidence observed in this study that these drugs could be either beneficial or harmful to wound healing.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

